Brandywine Oak Private Wealth’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-887
Closed -$217K 337
2021
Q2
$217K Buy
887
+30
+4% +$7.87K 0.03% 323
2021
Q1
$226K Sell
857
-54
-6% -$15.2K 0.03% 254
2020
Q4
$267K Buy
911
+10
+1% +$2.56K 0.04% 218
2020
Q3
$213K Buy
+901
New +$205K 0.04% 246

Other funds holding AMED

Brandywine Oak Private Wealth's AMED Position: Q3 2021 in Review

Brandywine Oak Private Wealth sold out of Amedisys (AMED) in Q3 2021, closing a stake of 887 shares — an estimated $217K sold.

Brandywine Oak Private Wealth first reported a position in AMED in Q3 2020 and held it in 4 quarters. The position peaked at $267K in Q4 2020. 351 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Brandywine Oak Private Wealth reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • Brandywine Oak Private Wealth sold 887 Amedisys shares in Q3 2021, an estimated $217K.
  • Brandywine Oak Private Wealth first reported a position in Amedisys in Q3 2020 and held it in 4 quarters.
  • Brandywine Oak Private Wealth's Amedisys position peaked at $267K in Q4 2020.
  • 351 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Brandywine Oak Private Wealth's 13F filing for Q3 2021, filed 18 Oct 2021.